UK Government Updates Smoking Cessation Guidelines for Doctors, Recognizes E-Cigarettes as Effective Aid

Apr.12.2022
A new smoking cessation guide for doctors in the UK emphasizes the potential harm reduction and quitting potential of e-cigarettes.

The UK government website has announced that the Office for Health Improvement and Disparities has released an updated quit smoking guide for doctors, highlighting the harm reduction and potential for quitting smoking with the aid of e-cigarettes in the section on smoking cessation aids.

 

It has been reported that currently 52.7% of smokers in the UK want to quit, but relying solely on willpower results in a low success rate. Therefore, professional guidance from doctors is crucial in assisting smokers to effectively use quitting aids and significantly improve their chances of success.

 

It is worth mentioning that this guideline highlights the harm reduction and smoking cessation potential of e-cigarettes in the section on smoking cessation assistance, particularly emphasizing the importance of informing doctors about them. The hope is that doctors can better understand e-cigarettes.

 

There is mounting evidence that shows the significant effectiveness of e-cigarettes as a tool for quitting smoking. A comprehensive review of studies conducted by the Cochrane Collaboration, an international organization of evidence-based medical professionals, in 2021 shows that e-cigarettes have a quit-smoking effect, with a success rate twice that of nicotine replacement therapy and nicotine-free e-cigarettes.

 

Source: Southern News Net.

 

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

NYSM Brand Strategy Unveiled, Unlocking a “Visible World”|CFU Vaping Experience Launches Six Product Series Under the “Clear Tank” Theme, Breaking the Boundaries of Traditional ODM
NYSM Brand Strategy Unveiled, Unlocking a “Visible World”|CFU Vaping Experience Launches Six Product Series Under the “Clear Tank” Theme, Breaking the Boundaries of Traditional ODM
Clear tank is becoming a key trend in the global vaping market, with large-capacity designs meeting consumer demand for “Simplicity and Ultimate Experience,” though leakage remains a major pain point. At the Inter Tabac 2025, CFU Vaping Experience launched its NYSM (Now You See Me) strategy around the “Clear Tank” theme, introducing six series and a “One-Stop Vape Brand Incubation” system. The initiative goes beyond traditional ODM, driving innovation and sustainable growth across the global vap
Sep.19
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International announced that the U.S. FDA has accepted the Abbreviated New Drug Application (ANDA) for its Breo® Ellipta® 100/25 generic drug, submitted by its wholly-owned subsidiary, Transpire Bio. Transpire Bio stated that if approved, it is expected to receive 180 days of market exclusivity. In the United States, Breo® Ellipta® is already approved for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD).
Sep.25 by 2FIRSTS.ai
Bhutan Implements New Tax Framework to Combat Non-Communicable Diseases and Reduce Alcohol and Tobacco Consumption
Bhutan Implements New Tax Framework to Combat Non-Communicable Diseases and Reduce Alcohol and Tobacco Consumption
New tax framework aimed at reducing alcohol and tobacco consumption to tackle rising non-communicable diseases crisis in Bhutan.
Sep.04 by 2FIRSTS.ai
China Tobacco Logistics Tech Partners with HERMA on Labeling Machine, Signaling CNTC’s Accelerated Move into Nicotine Pouches
China Tobacco Logistics Tech Partners with HERMA on Labeling Machine, Signaling CNTC’s Accelerated Move into Nicotine Pouches
China Tobacco Logistics Technology and Germany’s HERMA held their first joint review on oral nicotine pouch labeling machines, marking a step toward localized production. The cooperation signals CNTC’s potential preparation for nicotine pouch manufacturing, reinforcing market speculation.
Aug.25
Singapore's Narcotics Bureau cracked down on a criminal group smuggling etomidate-containing e-cigarettes for the first time, arresting 8 people and seizing a large number of cartridges
Singapore's Narcotics Bureau cracked down on a criminal group smuggling etomidate-containing e-cigarettes for the first time, arresting 8 people and seizing a large number of cartridges
CNB launches first major operation against e-liquid smuggling group in Singapore, arresting 7 men and 1 woman.
Sep.15 by 2FIRSTS.ai
Altria Raises Dividend to $1.06; Annual Payout Ratio Rises to 78%
Altria Raises Dividend to $1.06; Annual Payout Ratio Rises to 78%
U.S. tobacco giant Altria Group, Inc. (NYSE: MO) announced a 3.9% increase to its quarterly dividend, lifting the payout to $1.06 per share and bringing the annualized dividend to $4.24. Investment bank Stifel on August 21 maintained its “Buy” rating and raised its price target from $65 to $72. Backed by strong free cash flow, Altria expects to maintain mid-single-digit dividend growth going forward.
Aug.29 by 2FIRSTS.ai